Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$1.07 - $1.34 $1,391 - $1,742
1,300 Added 50.0%
3,900 $4,000
Q3 2022

Oct 25, 2022

BUY
$1.09 - $1.67 $1,962 - $3,006
1,800 Added 225.0%
2,600 $2,000
Q2 2022

Aug 04, 2022

BUY
$1.13 - $3.69 $112 - $369
100 Added 14.29%
800 $1,000
Q1 2022

Apr 14, 2022

SELL
$2.85 - $3.73 $13,395 - $17,531
-4,700 Reduced 87.04%
700 $2,000
Q4 2021

Jan 18, 2022

SELL
$3.24 - $5.18 $1,944 - $3,108
-600 Reduced 10.0%
5,400 $18,000
Q3 2021

Oct 26, 2021

SELL
$3.94 - $5.84 $17,336 - $25,696
-4,400 Reduced 42.31%
6,000 $30,000
Q2 2021

Jul 19, 2021

SELL
$4.26 - $6.5 $852 - $1,300
-200 Reduced 1.89%
10,400 $45,000
Q1 2021

Apr 26, 2021

SELL
$5.03 - $8.8 $65,893 - $115,280
-13,100 Reduced 55.27%
10,600 $65,000
Q4 2020

Jan 21, 2021

SELL
$4.04 - $5.31 $43,632 - $57,347
-10,800 Reduced 31.3%
23,700 $115,000
Q3 2020

Oct 27, 2020

BUY
$3.64 - $7.76 $68,068 - $145,112
18,700 Added 118.35%
34,500 $145,000
Q2 2020

Jul 22, 2020

SELL
$4.78 - $8.26 $358,944 - $620,268
-75,093 Reduced 82.62%
15,800 $109,000
Q1 2020

May 07, 2020

BUY
$4.0 - $21.53 $217,400 - $1.17 Million
54,350 Added 148.73%
90,893 $363,000
Q4 2019

Feb 06, 2020

SELL
$13.94 - $24.12 $110,920 - $191,922
-7,957 Reduced 17.88%
36,543 $783,000
Q3 2019

Oct 28, 2019

BUY
$13.89 - $23.16 $515,319 - $859,236
37,100 Added 501.35%
44,500 $674,000
Q2 2019

Aug 09, 2019

SELL
$16.27 - $20.51 $587,347 - $740,411
-36,100 Reduced 82.99%
7,400 $143,000
Q1 2019

May 10, 2019

SELL
$12.61 - $22.33 $233,688 - $413,819
-18,532 Reduced 29.87%
43,500 $903,000
Q4 2018

Feb 05, 2019

BUY
$12.41 - $22.98 $459,294 - $850,489
37,010 Added 147.91%
62,032 $844,000
Q3 2018

Nov 07, 2018

BUY
$2.45 - $16.27 $58,363 - $387,583
23,822 Added 1985.17%
25,022 $407,000
Q3 2017

Oct 17, 2017

BUY
$3.03 - $3.72 $3,635 - $4,464
1,200
1,200 $4,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.